Acute promyelocytic leukemia Primary Prevention: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no established measures for the primary prevention of | There are no established measures for the primary prevention of acute promyelocytic leukemia | ||
There are no available vaccines against acute promyelocytic leukemia . | |||
Effective measures for the primary prevention of acute promyelocytic leukemia in fatal is | |||
Effective measures for the primary prevention of acute promyelocytic leukemia | |||
==Primary Prevention== | ==Primary Prevention== | ||
There are no established measures for the primary prevention of | There are no established measures for the primary prevention of acute promyelocytic leukemia . | ||
There are no available vaccines against acute promyelocytic leukemia . | |||
Effective measures for the primary prevention of [disease name] include: | Effective measures for the primary prevention of [disease name] include: |
Revision as of 12:57, 25 January 2019
Acute promyelocytic leukemia Microchapters |
Differentiating Acute promyelocytic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Acute promyelocytic leukemia Primary Prevention On the Web |
American Roentgen Ray Society Images of Acute promyelocytic leukemia Primary Prevention |
Directions to Hospitals Treating Acute promyelocytic leukemia |
Risk calculators and risk factors for Acute promyelocytic leukemia Primary Prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
There are no established measures for the primary prevention of acute promyelocytic leukemia
There are no available vaccines against acute promyelocytic leukemia .
Effective measures for the primary prevention of acute promyelocytic leukemia in fatal is
Primary Prevention
There are no established measures for the primary prevention of acute promyelocytic leukemia .
There are no available vaccines against acute promyelocytic leukemia .
Effective measures for the primary prevention of [disease name] include:
- [Measure1]
- [Measure2]
- [Measure3]
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]